Evidence map›Paper›PMID 31899537›Full record

ArticleEuropean cells & materials2020

Functional cell phenotype induction with TGF-β1 and collagen-polyurethane scaffold for annulus fibrosus rupture repair.

J Du, R G Long, T Nakai, D Sakai, L M Benneker, G Zhou, B Li, D Eglin, J C Iatridis, M Alini and 2 more

Open access · goldAbstract read
In one paragraph

Article in European cells & materials, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Regenerative strategies for intervertebral disc degeneration.Journal of orthopaedic translation · 2025
    Review
  3. Article
  4. Review
  5. Frontiers in bioengineering and biotechnology · 2024
    Article
  6. Chemokines in Cartilage Regeneration and Degradation: New Insights.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Celecoxib alleviates nociceptor sensitization mediated by interleukin-1beta-primed annulus fibrosus cells.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2023
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

J Du
R G Long
T Nakai
D Sakai
L M Benneker
G Zhou
B Li
D Eglin
J C Iatridis
M Alini
S Grad
Z LiAO Research Institute Davos, Clavadelerstrasse 8, 7270, Davos Platz, Switzerland. zhen.li@aofoundation.org.
AO Foundation · CHTokai University · JPShenzhen University Health Science Center · CNSoochow University · CNUniversity of Bern · CH

Funding

Model of Human Disc Regeneration in the spectrum of Degenerative Disc DiseaseR01AR057397 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IATRIDIS, JAMES C. · 2011 to 2021
$5.1M
Notochordal Cell Derived Therapies for Painful Disc DegenerationR01AR064157 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IATRIDIS, JAMES C. · 2013 to 2017
$2.7M
NIAMS NIH HHS R01 AR057397NIAMS NIH HHS R01 AR064157
6 · The paper itself

Abstract

Appropriate cell sources, bioactive factors and biomaterials for generation of functional and integrated annulus fibrosus (AF) tissue analogues are still an unmet need. In the present study, the AF cell markers, collagen type I, cluster of differentiation 146 (CD146), mohawk (MKX) and smooth muscle protein 22α (SM22α) were found to be suitable indicators of functional AF cell induction. In vitro 2D culture of human AF cells showed that transforming growth factor β1 (TGF-β1) upregulated the expression of the functional AF markers and increased cell contractility, indicating that TGF-β1-pre-treated AF cells were an appropriate cell source for AF tissue regeneration. Furthermore, a tissue engineered construct, composed of polyurethane (PU) scaffold with a TGF-β1-supplemented collagen type I hydrogel and human AF cells, was evaluated with in vitro 3D culture and ex vivo preclinical bioreactor-loaded organ culture models. The collagen type I hydrogel helped maintaining the AF functional phenotype. TGF-β1 supplement within the collagen I hydrogel further promoted cell proliferation and matrix production of AF cells within in vitro 3D culture. In the ex vivo IVD organ culture model with physiologically relevant mechanical loading, TGF-β1 supplement in the transplanted constructs induced the functional AF cell phenotype and enhanced collagen matrix synthesis. In conclusion, TGF-β1-containing collagen-PU constructs can induce the functional cell phenotype of human AF cells in vitro and in situ. This combined cellular, biomaterial and bioactive agent therapy has a great potential for AF tissue regeneration and rupture repair.

Indexed as

AdultAnimalsAnnulus FibrosusBiomarkersCattleCells, CulturedCollagenFemaleGene Expression RegulationHumansMaleMiddle AgedOrgan Culture TechniquesPhenotypePolyurethanesRNA, MessengerBiomarkersCollagenPolyurethanesRNA, MessengerTransforming Growth Factor beta1

Identifiers

PMID31899537
PMCPMC7027376
OpenAlexW2998104687

What OpenQuestion holds

Textmetadata
LicenceCC BY-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.